Search Results - "Liang, Riying"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Liraglutide protects against high-fat diet-induced kidney injury by ameliorating apoptosis by Liang, Riying, Wang, Meijun, Fu, Chang, Liang, Hua, Deng, Hongrong, Tan, Ying, Xu, Fen, Cai, Mengyin

    Published in Endocrine Connections (01-10-2020)
    “…Background: Obesity is associated with the development and progression of chronic kidney disease. Emerging evidence suggests that glucagon-like peptide-1…”
    Get full text
    Journal Article
  2. 2

    520-P: Exenatide Ameliorates Diabetic Kidney Disease by Inhibiting Apoptosis via SIRT1/TXNIP Signal Pathway by WANG, MEIJUN, LIANG, RIYING, XU, FEN, CAI, MENGYIN

    Published in Diabetes (New York, N.Y.) (01-06-2020)
    “…Recent studies have indicated apoptosis to be a major contributor to the progression of Diabetic Kidney Disease. GLP-1 agonist such as Exenatide, which…”
    Get full text
    Journal Article
  3. 3

    1138-P: Empagliflozin Ameliorates Kidney Injury in Diabetic Nephropathy via SIRT1 and TXNIP by LIANG, RIYING, WANG, MEIJUN, XU, FEN, CAI, MENGYIN

    Published in Diabetes (New York, N.Y.) (01-06-2020)
    “…SGLT2 inhibitor empagliflozin can slower the decline of eGFR and reduce the occurrence rate of end-stage kidney disease according to EMPA-REG OUTCOME Clinical…”
    Get full text
    Journal Article
  4. 4

    2032-P: The Effects of Liraglutide on Ameliorating Diabetic Kidney Disease Is via SIRT1/TXNIP Pathway by LIANG, RIYING, WANG, MEIJUN, FU, CHANG, XU, FEN, CAI, MENGYIN

    Published in Diabetes (New York, N.Y.) (01-06-2019)
    “…GLP-1 receptor agonist is one of the most effective drugs to treat type 2 diabetes. LEADER Clinical Trials revealed that liraglutide exerted its renoprotective…”
    Get full text
    Journal Article